Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SNRK mRNA | CTD | PMID:36331819 | (S)-nicotine | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Nicotine results in decreased expression of SNRK mRNA | CTD | PMID:17997037 | 1,2-dimethylhydrazine | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNRK mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRK mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of SNRK mRNA | CTD | PMID:29097150 | 17beta-estradiol | affects expression | ISO | Snrk (Mus musculus) | 6480464 | Estradiol affects the expression of SNRK mRNA | CTD | PMID:15598610 | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:20959002 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRK mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SNRK mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNRK mRNA | CTD | PMID:23994337 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNRK mRNA and Tetrachlorodibenzodioxin results in decreased expression of SNRK protein | CTD | PMID:20959002 and PMID:31511937 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snrk (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNRK mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | SNRK (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNRK mRNA | CTD | PMID:22298810 | 2-ethoxyethanol | increases expression | EXP | | 6480464 | 2-ethoxyethanol results in increased expression of SNRK mRNA | CTD | PMID:19643169 | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of SNRK mRNA | CTD | PMID:19643169 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:23994337 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Snrk (Mus musculus) | 6480464 | bisphenol S affects the methylation of SNRK gene | CTD | PMID:31683443 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SNRK mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SNRK mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | SNRK (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of SNRK gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SNRK mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SNRK mRNA | CTD | PMID:16483693 | arsenite(3-) | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SNRK mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | decreases expression | ISO | SNRK (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SNRK mRNA | CTD | PMID:20498004 | benzo[a]pyrene | affects methylation | ISO | SNRK (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SNRK promoter | CTD | PMID:27901495 | beta-naphthoflavone | increases expression | ISO | Snrk (Mus musculus) | 6480464 | beta-Naphthoflavone results in increased expression of SNRK mRNA | CTD | PMID:23994337 | bisphenol A | increases expression | ISO | Snrk (Mus musculus) | 6480464 | bisphenol A results in increased expression of SNRK mRNA | CTD | PMID:26063408 and PMID:33221593 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SNRK mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SNRK mRNA | CTD | PMID:29097150 | bisphenol A | increases methylation | ISO | Snrk (Mus musculus) | 6480464 | bisphenol A results in increased methylation of SNRK promoter | CTD | PMID:27312807 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SNRK mRNA | CTD | PMID:25181051 | caffeine | affects phosphorylation | ISO | SNRK (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SNRK protein | CTD | PMID:35688186 | calcidiol | decreases expression | EXP | | 6480464 | Calcifediol deficiency results in decreased expression of SNRK mRNA | CTD | PMID:17293106 | calcitriol | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SNRK mRNA | CTD | PMID:16002434 | carbon nanotube | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | CGP 52608 | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SNRK gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Snrk (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of SNRK mRNA | CTD | PMID:37019170 | ciglitazone | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of SNRK mRNA | CTD | PMID:16197558 | cisplatin | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [Cisplatin co-treated with panobinostat] affects the expression of SNRK mRNA | CTD | PMID:21791302 | copper(II) sulfate | decreases expression | ISO | SNRK (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SNRK mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of SNRK mRNA | CTD | PMID:29279043 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of SNRK mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNRK mRNA | CTD | PMID:27188386 | endosulfan | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Endosulfan results in increased expression of SNRK mRNA | CTD | PMID:26615145 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of SNRK mRNA | CTD | PMID:29391264 | ethanol | affects splicing | ISO | Snrk (Mus musculus) | 6480464 | Ethanol affects the splicing of SNRK mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of SNRK mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNRK mRNA | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SNRK mRNA | CTD | PMID:25629700 | formaldehyde | decreases expression | ISO | SNRK (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of SNRK mRNA | CTD | PMID:20655997 | FR900359 | decreases phosphorylation | ISO | SNRK (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of SNRK protein | CTD | PMID:37730182 | Genipin | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | genipin inhibits the reaction [Lipopolysaccharides results in decreased expression of SNRK mRNA] | CTD | PMID:22687549 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SNRK mRNA | CTD | PMID:33387578 | kainic acid | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Kainic Acid results in decreased expression of SNRK mRNA | CTD | PMID:17997037 | lead(0) | affects expression | ISO | SNRK (Homo sapiens) | 6480464 | Lead affects the expression of SNRK mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | genipin inhibits the reaction [Lipopolysaccharides results in decreased expression of SNRK mRNA] | CTD | PMID:22687549 | lipopolysaccharide | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of SNRK mRNA | CTD | PMID:22687549 | methamphetamine | increases expression | ISO | Snrk (Mus musculus) | 6480464 | Methamphetamine results in increased expression of SNRK mRNA | CTD | PMID:26307267 | methamphetamine | increases methylation | ISO | Snrk (Mus musculus) | 6480464 | Methamphetamine results in increased methylation of SNRK promoter | CTD | PMID:26307267 | methyl methanesulfonate | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SNRK mRNA | CTD | PMID:23649840 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SNRK mRNA | CTD | PMID:25566086 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SNRK mRNA] | CTD | PMID:25566086 | nicotine | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Nicotine results in decreased expression of SNRK mRNA | CTD | PMID:17997037 | nitroglycerin | increases expression | EXP | | 6480464 | Nitroglycerin results in increased expression of SNRK mRNA | CTD | PMID:12102619 | ozone | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Ozone results in decreased expression of SNRK mRNA | CTD | PMID:12763052 | ozone | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SNRK mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SNRK mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [Cisplatin co-treated with panobinostat] affects the expression of SNRK mRNA | CTD | PMID:21791302 | paracetamol | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of SNRK mRNA | CTD | PMID:17585979 | paracetamol | affects expression | ISO | Snrk (Mus musculus) | 6480464 | Acetaminophen affects the expression of SNRK mRNA | CTD | PMID:17562736 | PCB138 | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Snrk (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SNRK mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SNRK mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | SNRK (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of SNRK mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNRK mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | ISO | Snrk (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SNRK mRNA | CTD | PMID:17426115 and PMID:18301758 | poly(I:C) | multiple interactions | EXP | | 6480464 | [Poly I-C co-treated with HU 211] results in decreased expression of SNRK mRNA | CTD | PMID:26923065 | progesterone | decreases expression | ISO | SNRK (Homo sapiens) | 6480464 | Progesterone results in decreased expression of SNRK mRNA | CTD | PMID:20864642 | SB 431542 | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNRK mRNA | CTD | PMID:27188386 | sodium arsenate | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of SNRK mRNA | CTD | PMID:30953684 | sodium arsenite | increases expression | ISO | Snrk (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SNRK protein | CTD | PMID:29044176 | sodium chloride | increases expression | EXP | | 6480464 | Sodium Chloride results in increased expression of SNRK mRNA | CTD | PMID:37992803 | sodium chloride | multiple interactions | EXP | | 6480464 | NFAT5 protein affects the reaction [Sodium Chloride results in increased expression of SNRK mRNA] | CTD | PMID:37992803 | sulforaphane | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | sulforaphane results in decreased expression of SNRK mRNA | CTD | PMID:30529165 | testosterone | increases expression | ISO | Snrk (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of SNRK mRNA | CTD | PMID:33848595 | tetrachloromethane | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of SNRK mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SNRK mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SNRK mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | ISO | Snrk (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of SNRK mRNA | CTD | PMID:19448997 | triptonide | increases expression | ISO | Snrk (Mus musculus) | 6480464 | triptonide results in increased expression of SNRK mRNA | CTD | PMID:33045310 | troglitazone | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | troglitazone results in decreased expression of SNRK mRNA | CTD | PMID:28973697 | tungsten | decreases expression | ISO | Snrk (Mus musculus) | 6480464 | Tungsten results in decreased expression of SNRK mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Urethane results in increased expression of SNRK mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | Snrk (Mus musculus) | 6480464 | Valproic Acid results in increased expression of SNRK mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | SNRK (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SNRK mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | SNRK (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SNRK mRNA | CTD | PMID:29154799 | zinc atom | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SNRK mRNA | CTD | PMID:18593933 | zinc sulfate | decreases expression | ISO | SNRK (Homo sapiens) | 6480464 | Zinc Sulfate results in decreased expression of SNRK mRNA | CTD | PMID:16330358 | zinc(0) | multiple interactions | ISO | SNRK (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SNRK mRNA | CTD | PMID:18593933 | |